Levonorgestrel-releasing intrauterine device in the treatment of menorrhagia

Br J Obstet Gynaecol. 1990 Aug;97(8):690-4. doi: 10.1111/j.1471-0528.1990.tb16240.x.

Abstract

In 20 women with menorrhagia (greater than 80 ml blood loss per menstrual period) a levonorgestrel-releasing intrauterine device (Lng-IUCD) was inserted. Menstrual blood loss (MBL) was measured in two consecutive cycles before the device was inserted and after 3, 6 and 12 months of use. MBL was significantly reduced after 3 months (86%) and after 12 months the reduction was 97%. There was a significant increase (P less than 0.001) in serum ferritin during the first year of Lng-IUCD use. The Lng-IUCD seems to be an important alternative to oral medication and to hysterectomy in the treatment of menorrhagia.

MeSH terms

  • Adult
  • Consumer Behavior
  • Contraceptive Agents, Female / administration & dosage*
  • Female
  • Ferritins / blood
  • Hemoglobins / analysis
  • Humans
  • Intrauterine Devices, Medicated*
  • Levonorgestrel
  • Menorrhagia / blood
  • Menorrhagia / drug therapy*
  • Middle Aged
  • Norgestrel / administration & dosage*
  • Prognosis
  • Quality of Life
  • Time Factors

Substances

  • Contraceptive Agents, Female
  • Hemoglobins
  • Norgestrel
  • Levonorgestrel
  • Ferritins